Delivery Order SPE2DB22D2108-SPE2DB25FU5FY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,954.85 to AmerisourceBergen Drug Corp for the supply of Chlorthalidone 25 mg tablets in quantities of 100 units. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, utilized firm fixed pricing and was not set aside for any socioeconomic category. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorthalidone 25 mg tablets. The $3,417.69 Firm Fixed Price contract has a completion date of May 11, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
- This federal contract award is for the delivery of chlorthalidone 25mg tablets, a generic pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, as a firm fixed price delivery order. The contract has a ceiling value of $2,778.31 and a performance period through March 15, 2024. No set-aside designation was used for this contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.34 firm fixed-price delivery order is for the supply of 1,000 units of the pharmaceutical Chlorthalidone 25 mg tablets, with a performance period through July 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,885.63 firm fixed price delivery order is for the supply of 4,559,544 units of chlorthalidone 25 mg tablets. The contract has an ultimate completion date of January 10, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.06 Firm Fixed Price Delivery Order contract is for the supply of CHLORTHALIDONE 25 MG TABLET 100S medical tablets, with a period of performance through May 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award is for the supply of Chlorthalidone 25 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,323.61, and has an ultimate completion date of June 16, 2023. The contract does not...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,674.50 contract is for the delivery of Chlorthalidone 25 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the supply of chlorthalidone 25 mg tablets in 100-count packages, with a ceiling value of $1,359.88 and an ultimate completion date of August 9, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor responsible for providing these medical supplies to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,586.39 for the procurement of 4,554,281,853 units of Chlorthalidone 25 mg tablets. The contract was awarded on July 30, 2021 by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 2, 2021. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5FYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,240.44 to AmerisourceBergen Drug Corp for the supply of Chlorthalidone 25 mg tablets (100-count units). This competitive award, issued on July 28, 2025, represents a firm fixed price delivery order with an ultimate completion date of July 29, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's existing DLA contract portfolio demonstrates capability across a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Chlorthalidone, a diuretic medication commonly used for hypertension management, represents the type of essential pharmaceutical commodity distributed through the company's federal supply network to support military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/28/25 |